St. Jude Medical announced new features for its Merlin.net remote patient monitoring offering, Patient Care Network (PCN), including mobile alerts for physicians and improved data export to EHRs.

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse™ implantable cardioverter ...

A spat involving St. Jude Medical and the medical journal HeartRhythm escalated sharply on 10 April, with HeartRhythm rebuffing St. Jude's requests to retract an article implying defibrillator leads ...

CHICAGO, June 23 (Reuters) - A pacemaker-like device made by St. Jude Medical Inc helped reduce patients' debilitating migraine headaches, the company said on Thursday, but Wall Street analysts said ...

The Food and Drug Administration has approved St. Jude Medical's new Ellipse implantable cardioverter defibrillator (ICD) and its Assura cardiac resynchronization therapy defibrillator (CRT-D), ...

CHICAGO (Reuters) - Twin setbacks for St Jude Medical Inc's heart rhythm devices are raising concerns on Wall Street that doctors will curb use of the company's products, weakening its position in the ...

The US Food and Drug Administration (FDA) and the Department of Homeland Security (DHS) Industrial Control Systems Cyber Emergency Response Team (ICS-CERT) issued an advisory on Monday warning of ...

St. Jude Medical, Inc., said Friday that its defibrillator lead that was removed from a patient in April and reported to be damaged did not have the same critical flaw as an older but similar line of ...

St. Jude Medical (NYSE:STJ) announced Monday that it has won regulatory approval from the European Union to market a smaller implantable cardioverter defibrillator. The Ellipse is the industry’s ...

St. Jude Medical, a medical device company, is seeking a retraction of a manuscript accepted for publication in the Heart Rhythm Journal that suggests its cardiac devices are prone to more deaths than ...